ADA/USDT 1DAY UPDATE BY CRYPTO SANDERS
Hello, welcome to this ADA/USD 1DAY chart update by CRYPTO SANDERS.
I have tried to bring the best possible outcome to this chart.
CHART ANALYSIS:-Cardano (ADA)
Cardano is about to close 2022 as one of its worst years. With a new low in 2022 at $0.24, there seems to be no stop to the current downtrend. After losing 5.7% of its valuation in the past seven days, ADA is still in search of support.
At this time, the most likely support level to stop the downtrend is found at $0.20. This key level may provide ADA with some relief because it could entice buyers to finally return after being absent for most of 2022.
Looking ahead, the outlook for this cryptocurrency remains bearish after losing more than 92% of its valuation since its all-time high at above $3. Hopefully, in 2023, ADA will be able to find support and start a sustained reversal to recover some of these most recent losses.
This is not a piece of financial advice.
Hit the like button if you like it and share your charts in the comments section.
Thank you
I have tried to bring the best possible outcome to this chart.
CHART ANALYSIS:-Cardano (ADA)
Cardano is about to close 2022 as one of its worst years. With a new low in 2022 at $0.24, there seems to be no stop to the current downtrend. After losing 5.7% of its valuation in the past seven days, ADA is still in search of support.
At this time, the most likely support level to stop the downtrend is found at $0.20. This key level may provide ADA with some relief because it could entice buyers to finally return after being absent for most of 2022.
Looking ahead, the outlook for this cryptocurrency remains bearish after losing more than 92% of its valuation since its all-time high at above $3. Hopefully, in 2023, ADA will be able to find support and start a sustained reversal to recover some of these most recent losses.
This is not a piece of financial advice.
Hit the like button if you like it and share your charts in the comments section.
Thank you
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.